Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections

It is well-established that botulinum toxin (BT) injections improve quality of life in patients with postparalytic hemifacial spasm. Nevertheless, injection-related pain and contracture-related pain have not yet been studied. The primary objective of our study was to evaluate injection-related pain...

Full description

Bibliographic Details
Main Authors: Chloé Wehrlin, Diane Picard, Frederic Tankéré, Rémi Hervochon, Claire Foirest
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/14/1/20
_version_ 1797490023158775808
author Chloé Wehrlin
Diane Picard
Frederic Tankéré
Rémi Hervochon
Claire Foirest
author_facet Chloé Wehrlin
Diane Picard
Frederic Tankéré
Rémi Hervochon
Claire Foirest
author_sort Chloé Wehrlin
collection DOAJ
description It is well-established that botulinum toxin (BT) injections improve quality of life in patients with postparalytic hemifacial spasm. Nevertheless, injection-related pain and contracture-related pain have not yet been studied. The primary objective of our study was to evaluate injection-related pain in patients with facial palsy sequelae, and to compare the standard technique (syringe) with the Juvapen device. The secondary objective was to evaluate the improvement of contracture-related pain one month after BT injection. Methods: We conducted an observational, prospective, monocentric study based on 60 patients with facial palsy sequelae who received BT injections in our university ENT (ear, nose throat) department. There were 30 patients in the Juvapen group (J) and 30 in the standard technique group (ST). All patients completed Numerical Rating Scale (NRS) questionnaires immediately after the injections and one month later. Results: The average NRS score was 1.33/10 with Juvapen and 2.24/10 with the standard technique (<i>p</i> = 0.0058; Z = 2.75). In patients with contracture-related pain, the average NRS score was 3.53 before BT injection, and 0.41 one month after BT injection (<i>p</i> = 0.0001). Conclusions: Juvapen is a less-painful injection technique than the standard one. BT reduces contracture-related pain one month after injection.
first_indexed 2024-03-10T00:25:03Z
format Article
id doaj.art-bee3fa1e5b0b48aeb262a7a9fce093ff
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-03-10T00:25:03Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-bee3fa1e5b0b48aeb262a7a9fce093ff2023-11-23T15:35:43ZengMDPI AGToxins2072-66512021-12-011412010.3390/toxins14010020Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin InjectionsChloé Wehrlin0Diane Picard1Frederic Tankéré2Rémi Hervochon3Claire Foirest4ENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, FranceENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, FranceENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, FranceENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, FranceENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, FranceIt is well-established that botulinum toxin (BT) injections improve quality of life in patients with postparalytic hemifacial spasm. Nevertheless, injection-related pain and contracture-related pain have not yet been studied. The primary objective of our study was to evaluate injection-related pain in patients with facial palsy sequelae, and to compare the standard technique (syringe) with the Juvapen device. The secondary objective was to evaluate the improvement of contracture-related pain one month after BT injection. Methods: We conducted an observational, prospective, monocentric study based on 60 patients with facial palsy sequelae who received BT injections in our university ENT (ear, nose throat) department. There were 30 patients in the Juvapen group (J) and 30 in the standard technique group (ST). All patients completed Numerical Rating Scale (NRS) questionnaires immediately after the injections and one month later. Results: The average NRS score was 1.33/10 with Juvapen and 2.24/10 with the standard technique (<i>p</i> = 0.0058; Z = 2.75). In patients with contracture-related pain, the average NRS score was 3.53 before BT injection, and 0.41 one month after BT injection (<i>p</i> = 0.0001). Conclusions: Juvapen is a less-painful injection technique than the standard one. BT reduces contracture-related pain one month after injection.https://www.mdpi.com/2072-6651/14/1/20facial palsypainbotulinum toxin
spellingShingle Chloé Wehrlin
Diane Picard
Frederic Tankéré
Rémi Hervochon
Claire Foirest
Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections
Toxins
facial palsy
pain
botulinum toxin
title Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections
title_full Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections
title_fullStr Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections
title_full_unstemmed Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections
title_short Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections
title_sort pain in patients with post paralytic hemifacial spasm before during and after botulinum toxin injections
topic facial palsy
pain
botulinum toxin
url https://www.mdpi.com/2072-6651/14/1/20
work_keys_str_mv AT chloewehrlin paininpatientswithpostparalytichemifacialspasmbeforeduringandafterbotulinumtoxininjections
AT dianepicard paininpatientswithpostparalytichemifacialspasmbeforeduringandafterbotulinumtoxininjections
AT frederictankere paininpatientswithpostparalytichemifacialspasmbeforeduringandafterbotulinumtoxininjections
AT remihervochon paininpatientswithpostparalytichemifacialspasmbeforeduringandafterbotulinumtoxininjections
AT clairefoirest paininpatientswithpostparalytichemifacialspasmbeforeduringandafterbotulinumtoxininjections